John Berk, MD

Associate Professor of Medicine, Pulmonary, Critical Care and Sleep Medicine, Boston University School of Medicine

Dr. Berk is assistant director of the Amyloidosis Center at Boston University Medical Center. He led the Diflunisal Trial, and has focused on drug development for ATTR amyloidosis for than 15 years. He and his research team have participated in all of the major clinical trials for patients with ATTR amyloid polyneuropathy and cardiomyopathy.